- Home
- ARCB vs AGIO Comparison
ARCB vs AGIO Comparison
Compare ARCB & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCB
- AGIO
- Stock Information
- Founded
- ARCB 1923
- AGIO 2007
- Country
- ARCB United States
- AGIO United States
- Employees
- ARCB N/A
- AGIO N/A
- Industry
- ARCB Trucking Freight/Courier Services
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- ARCB Industrials
- AGIO Health Care
- Exchange
- ARCB Nasdaq
- AGIO Nasdaq
- Market Cap
- ARCB 2.3B
- AGIO 2.0B
- IPO Year
- ARCB N/A
- AGIO 2013
- Fundamental
- Price
- ARCB $100.19
- AGIO $32.42
- Analyst Decision
- ARCB Buy
- AGIO Buy
- Analyst Count
- ARCB 14
- AGIO 7
- Target Price
- ARCB $129.92
- AGIO $56.33
- AVG Volume (30 Days)
- ARCB 276.7K
- AGIO 1.0M
- Earning Date
- ARCB 01-31-2025
- AGIO 02-13-2025
- Dividend Yield
- ARCB 0.48%
- AGIO N/A
- EPS Growth
- ARCB 8.96
- AGIO N/A
- EPS
- ARCB 8.07
- AGIO 11.80
- Revenue
- ARCB $4,266,908,999.00
- AGIO $32,871,000.00
- Revenue This Year
- ARCB N/A
- AGIO $33.41
- Revenue Next Year
- ARCB $4.53
- AGIO $172.14
- P/E Ratio
- ARCB $12.46
- AGIO $2.75
- Revenue Growth
- ARCB N/A
- AGIO 36.79
- 52 Week Low
- ARCB $91.01
- AGIO $20.96
- 52 Week High
- ARCB $153.60
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- ARCB 51.10
- AGIO 33.53
- Support Level
- ARCB $91.76
- AGIO $32.85
- Resistance Level
- ARCB $103.63
- AGIO $35.03
- Average True Range (ATR)
- ARCB 2.95
- AGIO 1.75
- MACD
- ARCB 1.28
- AGIO 0.48
- Stochastic Oscillator
- ARCB 72.74
- AGIO 22.40
About ARCB ArcBest Corporation
ArcBest Corp is engaged in logistics operations. The company operates in two operating segments, The Asset-Based segment includes the results of operations of ABF Freight System, Inc. and certain other subsidiaries. The segment operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed LTL services. The services including freight transportation related to managed transportation solutions and other services. The Asset-Light segment includes the results of operations of the Company's service offerings in truckload, ground expedite, dedicated, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.